What are the major opportunities in the Methylmalonic Acidemia (MMA) market? What are the strategies for the Methylmalonic Acidemia (MMA) market?

For detailed insights on the major opportunities and strategies in the Methylmalonic Acidemia (MMA) market, Read More

How does the Methylmalonic Acidemia (MMA) market relate to the overall economy and other similar markets?

For detailed insights on Methylmalonic Acidemia (MMA)'s relation to the overall economy and other similar markets, Read More

What are the key dynamics influencing the Methylmalonic Acidemia (MMA) market growth? SWOT analysis of the Methylmalonic Acidemia (MMA) market.

For detailed insights on the key dynamics influencing the Methylmalonic Acidemia (MMA) market growth and SWOT analysis of the Methylmalonic Acidemia (MMA) industry, Read More

Methylmalonic Acidemia (MMA) Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Methylmalonic Acidemia (MMA) Market Report 2026

Name: Methylmalonic Acidemia (MMA) Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Treatment Type (Dietary Management And Supplementation, Enzyme Replacement Therapy, Gene Therapy, Transplantation), By Disorder Type (Isolated Methylmalonic Aciduria, Combined Methylmalonic Aciduria, Homocystinuria), By Patient Age Group (Infant, Pediatric, Adult), By Route of Administration (Oral, Intravenous), By End User (Hospitals, Specialty Clinics, Homecare, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Methylmalonic Acidemia (MMA) Market Overview

• Methylmalonic Acidemia (MMA) market size has reached to $9.94 billion in 2025

• Expected to grow to $13.06 billion in 2030 at a compound annual growth rate (CAGR) of 5.6%

• Growth Driver: Rising Incidence Of Metabolic Disorders And Vitamin Deficiencies Driving The Growth Of The Market Due To Impaired Vitamin B12 Metabolism

• Market Trend: Innovative mRNA-Based Therapies Pave The Way For Advanced Treatments

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Methylmalonic Acidemia (MMA) Market?

Methylmalonic acidemia (MMA) is a rare, inherited metabolic disorder in which the body is unable to properly break down specific proteins and fats due to a deficiency in the enzyme methylmalonyl-CoA mutase or a related coenzyme, vitamin B12. The symptoms of MMA can vary in severity but often include vomiting, lethargy, poor feeding, developmental delay, seizures, and failure to thrive.

The main indication types of methylmalonic acidemia (MMA) are acidosis, ketosis, hyperammonemia, hypoglycemia, hyperglycemia, neutropenia, and other indications. Acidosis is a condition in which there is an excess of acid in the blood, leading to a lower-than-normal pH level. There are different disorder types, like homocystinuria, isolated methylmalonic acidurias, and combined methylmalonic aciduria. It is through various distribution channels, such as hospitals, pharmacies, clinics, and other distribution channels.

Methylmalonic Acidemia (MMA) Market Global Report 2026 Market Report bar graph

What Is The Methylmalonic Acidemia (MMA) Market Size and Share 2026?

The methylmalonic acidemia (mma) market size has grown strongly in recent years. It will grow from $9.94 billion in 2025 to $10.52 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increase in rare disease awareness, rise in newborn screening programs, expansion of metabolic disorder research, improved diagnostic technologies, early genetic testing adoption.

What Is The Methylmalonic Acidemia (MMA) Market Growth Forecast?

The methylmalonic acidemia (mma) market size is expected to see strong growth in the next few years. It will grow to $13.06 billion in 2030 at a compound annual growth rate (CAGR) of 5.6%. The growth in the forecast period can be attributed to growth in precision therapeutics, advancement in gene and enzyme replacement therapies, rising investment in rare disease drug pipelines, expanding telehealth-based metabolic monitoring, increasing focus on personalized nutrition management. Major trends in the forecast period include precision medicine-based therapy development, AI-assisted diagnosis and monitoring, cloud-based rare disease data integration, automated biomanufacturing for enzyme therapies, immersive medical training for metabolic disorders.

Book your 30 minutes free consultation with our research experts

Global Methylmalonic Acidemia (MMA) Market Segmentation

1) By Treatment Type: Dietary Management And Supplementation, Enzyme Replacement Therapy, Gene Therapy, Transplantation

2) By Disorder Type: Isolated Methylmalonic Aciduria, Combined Methylmalonic Aciduria, Homocystinuria

3) By Patient Age Group: Infant, Pediatric, Adult

4) By Route of Administration: Oral, Intravenous

5) By End User: Hospitals, Specialty Clinics, Homecare, Other End Users

Subsegments:

1) By Dietary Management And Supplementation: Vitamin B12 Supplementation, L-Carnitine Supplementation, Low-Protein Medical Diets

2) By Enzyme Replacement Therapy: Recombinant Enzyme Therapies, Investigational Enzymes

3) By Gene Therapy: AAV-Based Gene Therapy, Other Viral Vector-Based Therapies

4) By Transplantation: Liver Transplantation, Combined Liver–Kidney Transplantation

What Are The Drivers Of The Methylmalonic Acidemia (MMA) Market?

The increasing incidence of metabolic disorders and vitamin deficiencies is expected to propel the growth of the methylmalonic acidemia (MMA) market going forward. Metabolic disorders are a group of conditions in which the body has trouble processing certain nutrients, producing energy, or regulating chemical reactions within cells. Vitamin deficiencies occur when the body lacks enough specific vitamins to perform normal functions. The rise in metabolic disorders and vitamin deficiencies is due to unhealthy diets, sedentary lifestyles, and increased stress levels. Modern diets are often high in processed foods, sugars, and unhealthy fats while low in essential nutrients, leading to deficiencies in vitamins and minerals. Metabolic disorders and vitamin deficiencies, particularly vitamin B12 deficiency, impair methylmalonyl-CoA metabolism, accumulating methylmalonic acid and exacerbating methylmalonic acidemia (MMA). For instance, in November 2024, according to the National Institutes of Health, a US-based government agency, the prevalence of vitamin B12 deficiency increased from 4.6% to 5.2%, representing an additional 507 cases between the third and fourth quarters of 2023. Therefore, the increasing incidence of metabolic disorders and vitamin deficiencies drives the growth of the methylmalonic acidemia (MMA) industry.

The increasing neonatal and pediatric population is expected to propel the growth of the methylmalonic acidemia market going forward. The neonatal and pediatric population refers to newborns within the first 28 days of life and children under the age of 18 years. The rising neonatal and pediatric population is largely driven by improved maternal healthcare and neonatal care services, which have increased survival rates and reduced infant mortality in developed nations. The growing neonatal and pediatric population boosts demand for early diagnosis and treatment of metabolic disorders through expanded newborn screening programs. For instance, in October 2025, according to the Australian Bureau of Statistics, an Australia-based government agency, in 2024, a total of 292,318 births were registered, reflecting a 1.9% rise (an additional 5,320 births) compared to 2023, with 150,299 male and 142,019 female babies. Therefore, the increasing neonatal and pediatric population is driving the growth of the methylmalonic acidemia market.

Key Players In The Global Methylmalonic Acidemia (MMA) Market

Major companies operating in the methylmalonic acidemia (mma) market are Alexion Pharmaceuticals Inc., PTC Therapeutics Inc., Asklepios BioPharmaceutical Inc AskBio, Selecta Biosciences Inc, BridgeBio Pharma Inc., VectivBio Holding AG, Recordati Rare Diseases Inc., Agios Pharmaceuticals Inc., LogicBio Therapeutics Inc., Moderna Inc., Wockhardt Limited, Supriya Lifescience Ltd., HemoShear Therapeutics LLC, Deccan Nutraceuticals Pvt Ltd, Genespire, Bluebird Bio Inc, Takeda Pharmaceutical Company Limited, Sanofi, Orphan Technologies Ltd, Ultragenyx Pharmaceutical Inc, HemoShear Therapeutics LLC

Global Methylmalonic Acidemia (MMA) Market Trends and Insights

Major companies operating in the methylmalonic acidemia (MMA) market are focusing on developing innovative solutions, such as mRNA-based therapies, to improve treatment outcomes by targeting the underlying genetic causes of MMA and enhancing enzyme function to reduce the accumulation of toxic metabolites in affected individuals. mRNA-based therapies are a type of treatment that uses messenger RNA to instruct cells to produce specific proteins that can help prevent or treat diseases, such as genetic disorders or infections. For instance, in June 2024, Moderna, Inc., a US-based pharmaceutical and biotechnology company, received U.S. Food and Drug Administration (FDA) approval for including mRNA-3705 in the START pilot program, marking a significant step in advancing treatments for rare diseases. mRNA-3705 is an investigational therapy for methylmalonic acidemia (MMA) caused by MUT deficiency, designed to restore the missing enzyme using mRNA technology. The therapy leverages Moderna's proprietary lipid nanoparticle (LNP) system, also utilized in the mRNA-3927 program for propionic acidemia. The FDA has granted mRNA-3705 orphan drugs, fast track, and rare pediatric disease designations, facilitating its accelerated development and clinical progress.

Need data on a specific region in this market?

Request Regional Data

Regional Outlook

North America was the largest region in the methylmalonic acidemia (MMA) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Methylmalonic Acidemia (MMA) Market?

The methylmalonic acidemia (MMA) market consists of revenues earned by entities by providing services such as medical management, dietary support, and vitamin and medication therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The methylmalonic acidemia market includes sales of hydroxocobalamin, vitamin B12 tablets, other pharmaceutical and therapeutic products, dietary products, and diagnostic tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Methylmalonic Acidemia (MMA) Market Report 2026?

The methylmalonic acidemia (mma) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the methylmalonic acidemia (mma) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Methylmalonic Acidemia (MMA) Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$10.52 billion
Revenue Forecast In 2035	$13.06 billion
Growth Rate	CAGR of 5.8% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Treatment Type, Disorder Type, Patient Age Group, Route of Administration, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Alexion Pharmaceuticals Inc., PTC Therapeutics Inc., Asklepios BioPharmaceutical Inc AskBio, Selecta Biosciences Inc, BridgeBio Pharma Inc., VectivBio Holding AG, Recordati Rare Diseases Inc., Agios Pharmaceuticals Inc., LogicBio Therapeutics Inc., Moderna Inc., Wockhardt Limited, Supriya Lifescience Ltd., HemoShear Therapeutics LLC, Deccan Nutraceuticals Pvt Ltd, Genespire, Bluebird Bio Inc, Takeda Pharmaceutical Company Limited, Sanofi, Orphan Technologies Ltd, Ultragenyx Pharmaceutical Inc, HemoShear Therapeutics LLC
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Methylmalonic Acidemia (MMA) Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Methylmalonic Acidemia (MMA) Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Methylmalonic Acidemia (MMA) Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Methylmalonic Acidemia (MMA) Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Immersive Technologies (Ar/Vr/Xr) & Digital Experiences

4.2. Major Trends

4.2.1 Precision Medicine-Based Therapy Development

4.2.2 AI-Assisted Diagnosis And Monitoring

4.2.3 Cloud-Based Rare Disease Data Integration

4.2.4 Automated Biomanufacturing For Enzyme Therapies

4.2.5 Immersive Medical Training For Metabolic Disorders

5. Methylmalonic Acidemia (MMA) Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Metabolic Clinics

5.3 Diagnostic Laboratories

5.4 Research Institutes

5.5 Pediatric Care Centers

6. Methylmalonic Acidemia (MMA) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Methylmalonic Acidemia (MMA) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Methylmalonic Acidemia (MMA) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Methylmalonic Acidemia (MMA) Market Size, Comparisons And Growth Rate Analysis

7.3. Global Methylmalonic Acidemia (MMA) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Methylmalonic Acidemia (MMA) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Methylmalonic Acidemia (MMA) Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Methylmalonic Acidemia (MMA) Market Segmentation

9.1. Global Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Dietary Management and Supplementation, Enzyme Replacement Therapy, Gene Therapy, Transplantation

9.2. Global Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Isolated Methylmalonic Aciduria, Combined Methylmalonic Aciduria, Homocystinuria

9.3. Global Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Infant, Pediatric, Adult

9.4. Global Methylmalonic Acidemia (MMA) Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Intravenous

9.5. Global Methylmalonic Acidemia (MMA) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Specialty Clinics, Homecare, Other End Users

9.6. Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Dietary Management and Supplementation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Vitamin B12 Supplementation, L-Carnitine Supplementation, Low-Protein Medical Diets

9.7. Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Enzyme Replacement Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Recombinant Enzyme Therapies, Investigational Enzymes

9.8. Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

AAV-Based Gene Therapy, Other Viral Vector-Based Therapies

9.9. Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Transplantation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Liver Transplantation, Combined Liver–Kidney Transplantation

10. Methylmalonic Acidemia (MMA) Market Regional And Country Analysis

10.1. Global Methylmalonic Acidemia (MMA) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Methylmalonic Acidemia (MMA) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Methylmalonic Acidemia (MMA) Market

11.1. Asia-Pacific Methylmalonic Acidemia (MMA) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Methylmalonic Acidemia (MMA) Market

12.1. China Methylmalonic Acidemia (MMA) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Methylmalonic Acidemia (MMA) Market

13.1. India Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Methylmalonic Acidemia (MMA) Market

14.1. Japan Methylmalonic Acidemia (MMA) Market Overview

14.2. Japan Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Methylmalonic Acidemia (MMA) Market

15.1. Australia Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Methylmalonic Acidemia (MMA) Market

16.1. Indonesia Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Methylmalonic Acidemia (MMA) Market

17.1. South Korea Methylmalonic Acidemia (MMA) Market Overview

17.2. South Korea Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Methylmalonic Acidemia (MMA) Market

18.1. Taiwan Methylmalonic Acidemia (MMA) Market Overview

18.2. Taiwan Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Methylmalonic Acidemia (MMA) Market

19.1. South East Asia Methylmalonic Acidemia (MMA) Market Overview

19.2. South East Asia Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Methylmalonic Acidemia (MMA) Market

20.1. Western Europe Methylmalonic Acidemia (MMA) Market Overview

20.2. Western Europe Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Methylmalonic Acidemia (MMA) Market

21.1. UK Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Methylmalonic Acidemia (MMA) Market

22.1. Germany Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Methylmalonic Acidemia (MMA) Market

23.1. France Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Methylmalonic Acidemia (MMA) Market

24.1. Italy Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Methylmalonic Acidemia (MMA) Market

25.1. Spain Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Methylmalonic Acidemia (MMA) Market

26.1. Eastern Europe Methylmalonic Acidemia (MMA) Market Overview

26.2. Eastern Europe Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Methylmalonic Acidemia (MMA) Market

27.1. Russia Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Methylmalonic Acidemia (MMA) Market

28.1. North America Methylmalonic Acidemia (MMA) Market Overview

28.2. North America Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Methylmalonic Acidemia (MMA) Market

29.1. USA Methylmalonic Acidemia (MMA) Market Overview

29.2. USA Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Methylmalonic Acidemia (MMA) Market

30.1. Canada Methylmalonic Acidemia (MMA) Market Overview

30.2. Canada Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Methylmalonic Acidemia (MMA) Market

31.1. South America Methylmalonic Acidemia (MMA) Market Overview

31.2. South America Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Methylmalonic Acidemia (MMA) Market

32.1. Brazil Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Methylmalonic Acidemia (MMA) Market

33.1. Middle East Methylmalonic Acidemia (MMA) Market Overview

33.2. Middle East Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Methylmalonic Acidemia (MMA) Market

34.1. Africa Methylmalonic Acidemia (MMA) Market Overview

34.2. Africa Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Segmentation By Disorder Type, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Methylmalonic Acidemia (MMA) Market Regulatory and Investment Landscape

36. Methylmalonic Acidemia (MMA) Market Competitive Landscape And Company Profiles

36.1. Methylmalonic Acidemia (MMA) Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Methylmalonic Acidemia (MMA) Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Methylmalonic Acidemia (MMA) Market Company Profiles

36.3.1. Alexion Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. PTC Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Asklepios BioPharmaceutical Inc (AskBio) Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Selecta Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. BridgeBio Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Methylmalonic Acidemia (MMA) Market Other Major And Innovative Companies

VectivBio Holding AG, Recordati Rare Diseases Inc., Agios Pharmaceuticals Inc., LogicBio Therapeutics Inc., Moderna Inc., Wockhardt Limited, Supriya Lifescience Ltd., HemoShear Therapeutics LLC, Deccan Nutraceuticals Pvt Ltd, Genespire, Bluebird Bio Inc., Takeda Pharmaceutical Company Limited, Sanofi, Orphan Technologies Ltd, Ultragenyx Pharmaceutical Inc

38. Global Methylmalonic Acidemia (MMA) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Methylmalonic Acidemia (MMA) Market

40. Methylmalonic Acidemia (MMA) Market High Potential Countries, Segments and Strategies

40.1 Methylmalonic Acidemia (MMA) Market In 2030 - Countries Offering Most New Opportunities

40.2 Methylmalonic Acidemia (MMA) Market In 2030 - Segments Offering Most New Opportunities

40.3 Methylmalonic Acidemia (MMA) Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Methylmalonic Acidemia (MMA) Market, Overview Of Key Products - Product Examples

Table 2: Global Methylmalonic Acidemia (MMA) Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Methylmalonic Acidemia (MMA) Market, Supply Chain Analysis

Table 4: Global Methylmalonic Acidemia (MMA) Market, Major Raw Material Providers

Table 5: Global Methylmalonic Acidemia (MMA) Market, Major Resource Providers

Table 6: Global Methylmalonic Acidemia (MMA) Market, Major Manufacturers (Suppliers)

Table 7: Global Methylmalonic Acidemia (MMA) Market, Major Distributors And Channel Partners

Table 8: Global Methylmalonic Acidemia (MMA) Market, Key Technologies & Future Trends

Table 9: Global Methylmalonic Acidemia (MMA) Market, Major Trends

Table 10: Global Methylmalonic Acidemia (MMA) Market, Major End Users

Table 11: Global Methylmalonic Acidemia (MMA) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Methylmalonic Acidemia (MMA) Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Methylmalonic Acidemia (MMA) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Methylmalonic Acidemia (MMA) Market - TAM, US$ Billion, 2025

Table 15: Global Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Methylmalonic Acidemia (MMA) Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Methylmalonic Acidemia (MMA) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Dietary Management and Supplementation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Enzyme Replacement Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Transplantation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Methylmalonic Acidemia (MMA) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Global Methylmalonic Acidemia (MMA) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: Asia-Pacific, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: China, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: India, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Japan, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Australia, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: Indonesia, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: South Korea, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: Taiwan, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: South East Asia, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: Western Europe, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: UK, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: Germany, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: France, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Italy, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Spain, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Eastern Europe, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: Russia, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: North America, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: USA, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: Canada, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: South America, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Brazil, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Middle East, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Africa, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 98: Global Methylmalonic Acidemia (MMA) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 99: Global Methylmalonic Acidemia (MMA) Market - Company Scoring Matrix

Table 100: Alexion Pharmaceuticals Inc. Financial Performance

Table 101: PTC Therapeutics Inc. Financial Performance

Table 102: Asklepios BioPharmaceutical Inc (AskBio) Financial Performance

Table 103: Selecta Biosciences Inc. Financial Performance

Table 104: BridgeBio Pharma Inc. Financial Performance

Table 105: Global Methylmalonic Acidemia (MMA) Market, Competitive Benchmarking (In USD Billions)

Table 106: Global Methylmalonic Acidemia (MMA) Market, Competitive Dashboard

Table 107: Global Methylmalonic Acidemia (MMA) Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 108: Global, Methylmalonic Acidemia (MMA) Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030

Table 109: Global, Methylmalonic Acidemia (MMA) Market Size Gain ($ Billion), Segmentation By Disorder Type, 2025 – 2030

Table 110: Global, Methylmalonic Acidemia (MMA) Market Size Gain ($ Billion), Segmentation By Patient Age Group, 2025 – 2030

List Of Figures

Figure 1: Global Methylmalonic Acidemia (MMA) Market, Overview Of Key Products - Product Examples

Figure 2: Global Methylmalonic Acidemia (MMA) Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Methylmalonic Acidemia (MMA) Market, Supply Chain Analysis

Figure 4: Global Methylmalonic Acidemia (MMA) Market, Major Raw Material Providers

Figure 5: Global Methylmalonic Acidemia (MMA) Market, Major Resource Providers

Figure 6: Global Methylmalonic Acidemia (MMA) Market, Major Manufacturers (Suppliers)

Figure 7: Global Methylmalonic Acidemia (MMA) Market, Major Distributors And Channel Partners

Figure 8: Global Methylmalonic Acidemia (MMA) Market, Key Technologies & Future Trends

Figure 9: Global Methylmalonic Acidemia (MMA) Market, Major Trends

Figure 10: Global Methylmalonic Acidemia (MMA) Market, Major End Users

Figure 11: Global Methylmalonic Acidemia (MMA) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Methylmalonic Acidemia (MMA) Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Methylmalonic Acidemia (MMA) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Methylmalonic Acidemia (MMA) Market - TAM, US$ Billion, 2025

Figure 15: Global Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Methylmalonic Acidemia (MMA) Market, Segmentation By Route of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Methylmalonic Acidemia (MMA) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Dietary Management and Supplementation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Enzyme Replacement Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Gene Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Methylmalonic Acidemia (MMA) Market, Sub-Segmentation Of Transplantation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Methylmalonic Acidemia (MMA) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Global Methylmalonic Acidemia (MMA) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: Asia-Pacific, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: China, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: India, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Japan, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Australia, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: Indonesia, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: South Korea, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: Taiwan, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: South East Asia, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: Western Europe, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: UK, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: Germany, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: France, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Italy, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Spain, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Eastern Europe, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: Russia, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: North America, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: USA, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: Canada, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: South America, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Brazil, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Middle East, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Methylmalonic Acidemia (MMA) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Methylmalonic Acidemia (MMA) Market, Segmentation By Disorder Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Africa, Methylmalonic Acidemia (MMA) Market, Segmentation By Patient Age Group, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 98: Global Methylmalonic Acidemia (MMA) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 99: Global Methylmalonic Acidemia (MMA) Market - Company Scoring Matrix

Figure 100: Alexion Pharmaceuticals Inc. Financial Performance

Figure 101: PTC Therapeutics Inc. Financial Performance

Figure 102: Asklepios BioPharmaceutical Inc (AskBio) Financial Performance

Figure 103: Selecta Biosciences Inc. Financial Performance

Figure 104: BridgeBio Pharma Inc. Financial Performance

Figure 105: Global Methylmalonic Acidemia (MMA) Market, Competitive Benchmarking (In USD Billions)

Figure 106: Global Methylmalonic Acidemia (MMA) Market, Competitive Dashboard

Figure 107: Global Methylmalonic Acidemia (MMA) Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 108: Global, Methylmalonic Acidemia (MMA) Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030

Figure 109: Global, Methylmalonic Acidemia (MMA) Market Size Gain ($ Billion), Segmentation By Disorder Type, 2025 – 2030

Figure 110: Global, Methylmalonic Acidemia (MMA) Market Size Gain ($ Billion), Segmentation By Patient Age Group, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Alpha Methyldopa Market Report 2026 - Global Outlook – By Type (Oral, Intravenous Drip), By Purity Type (Purity (=98%, Purity (=99%), By Application (Parkinsonism, Hepatic Coma) – Market Size, Trends, Strategies, and For...

Glutamic Acid Market Report 2026 - Global Outlook – By Product (Biosynthesis, Industrial Synthesis), By Source (Plant-Based, Animal Based), By Application (Pharmaceutical, Food Additives, Animal and Pet Food, Other Appli...

Hydrochloric Acid Market Report 2026 - Global Outlook – By Type (Synthetic Hydrochloric Acid, By-Product Hydrochloric Acid), By Form (Water-Based, Aqueous, Solution), By Distribution Channel (E-Commerce, B2B, Specialty S...

Hydroxypropyl Methylcellulose Market Report 2026 - Global Outlook – By Product Types (Pharmaceutical Grade, Industrial Grade), By Sales Channel (Direct Sale, Indirect Sale), By End Use (Construction, Pharmaceuticals (Inc...

Anthracycline Market Report 2026 - Global Outlook – By Drugs (Daunorubicin, Doxorubicin, Epirubicin, Idarubicin, Valrubicin), By Dosage (Powder, Solution, Injection, Other Dosages), By Application (Acute Lymphocytic Leuk...

Leqembi Market Report 2026 - Epidemiology, Pipeline Analysis, Market Insights & Forecasts...

Octadecanedioic Acid Market Report 2026 - Global Outlook – By Product Type (Powder, Liquid ), By Application (Polyester Polyols, Lubricants and Greases, Powder Coatings, Personal Care Products, Other Applications ), By E...

Frequently Asked Questions

How big is the Methylmalonic Acidemia (MMA) Market?

The Methylmalonic Acidemia (MMA) market was valued at $9.94 billion in 2025, increased to $10.52 billion in 2026, and is projected to reach $13.06 billion by 2030.

What is the Methylmalonic Acidemia (MMA) market growth?

The global Methylmalonic Acidemia (MMA) market is expected to grow at a CAGR of 5.6% from 2026 to 2035 to reach $13.06 billion by 2035.

Who are the key players in Methylmalonic Acidemia (MMA) market?

Some Key Players in the Methylmalonic Acidemia (MMA) market Include, Alexion Pharmaceuticals Inc., PTC Therapeutics Inc., Asklepios BioPharmaceutical Inc AskBio, Selecta Biosciences Inc, BridgeBio Pharma Inc., VectivBio Holding AG, Recordati Rare Diseases Inc., Agios Pharmaceuticals Inc., LogicBio Therapeutics Inc., Moderna Inc., Wockhardt Limited, Supriya Lifescience Ltd., HemoShear Therapeutics LLC, Deccan Nutraceuticals Pvt Ltd, Genespire, Bluebird Bio Inc, Takeda Pharmaceutical Company Limited, Sanofi, Orphan Technologies Ltd, Ultragenyx Pharmaceutical Inc, HemoShear Therapeutics LLC .

What is the anticipated growth trend for the Methylmalonic Acidemia (MMA) market?

Major trend in this market includes: Innovative mRNA-Based Therapies Pave The Way For Advanced Treatments. For further insights on this market. request a sample here

Which region has the most growth potential in the Methylmalonic Acidemia (MMA) market?

North America was the largest region in the methylmalonic acidemia (MMA) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the methylmalonic acidemia (mma) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.